Wikisage, the free encyclopedia of the second generation, is digital heritage

Hyperhomocysteinemia: Difference between revisions

From Wikisage
Jump to navigation Jump to search
(add ref)
(ref)
Line 13: Line 13:
*Maryam Amini et al 2015
*Maryam Amini et al 2015
*[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431359/ Vitamin B12 supplementation in end stage renal diseases: a systematic review] Med J Islam Repub Iran. 29: 167
*[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431359/ Vitamin B12 supplementation in end stage renal diseases: a systematic review] Med J Islam Repub Iran. 29: 167
*Joseph E. Baggott and Tsunenobu Tamura 215 [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344578/pdf/nutrients-07-01108.pdf Homocysteine, Iron and Cardiovascular Disease: A Hypothesis Homocysteine, Iron and Cardiovascular Disease: A Hypothesis ] Nutrients 7, 1108-1118; doi:10.3390/nu7021108


[[nl:Hyperhomocysteïnemie]]
[[nl:Hyperhomocysteïnemie]]

Revision as of 00:05, 29 July 2015

Hyperhomocysteinemia or hyperhomocysteinaemia is a medical condition characterized by an abnormally high level of homocysteine in the blood, conventionally described as above 15 µmol/L

Disease classification WHO
hyperhomocisteinaemia E 72.1

Links

Numata et al.2015

La metilación global del ADN y los niveles de homocisteína en plasma se encuentran disminuidos en pacientes con diabetes mellitus tipo 1 (Global DNA methylation and homocysteine levels are lower in type 1 diabetes patients) Rev Med Chile: 143: 562-568

  • Peirong Huang et al 2015

Homocysteine and the risk of age-related macular degeneration: a systematic review and meta-analysis Sci Rep